Oxular Ltd Revenue and Competitors
Estimated Revenue & Valuation
- Oxular Ltd's estimated annual revenue is currently $5.3M per year.
- Oxular Ltd's estimated revenue per employee is $155,000
Employee Data
- Oxular Ltd has 34 Employees.
- Oxular Ltd grew their employee count by -17% last year.
Oxular Ltd's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP - Quality | Reveal Email/Phone |
3 | Associate Director Procurement and Supply Chain | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | Finance Director | Reveal Email/Phone |
6 | Director Information Management | Reveal Email/Phone |
7 | Finance Director | Reveal Email/Phone |
8 | Senior Project Manager | Reveal Email/Phone |
Oxular Ltd Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Oxular Ltd?
“One treatment a year. Life changing.†Oxular is developing disruptive treatments for retinal diseases. Oxular's sustained-release formulations are engineered to last up to one year following single administration and perform in specific small spaces in the eye. This approach provides unique and precise drug distribution to tissues specifically involved in retinal diseases. Oxular's drug administration technology is engineered to access these critical tissues through minimally invasive delivery. This unique combination aims to substantially improve patient quality of life by increasing therapeutic effectiveness and patient safety, while reducing side-effects and minimizing the frequency of treatments. Oxular's product development pipeline includes treatments for prevalent retinal diseases, such as diabetic macular edema, as well as rare and orphan indications, including treatments for ocular cancers.
keywords:N/A
N/A
Total Funding
34
Number of Employees
$5.3M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Oxford
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.8M | 34 | 10% | N/A |
#2 | $6.5M | 34 | 0% | N/A |
#3 | $2.7M | 34 | 26% | N/A |
#4 | $4.8M | 34 | 31% | N/A |
#5 | $3.9M | 34 | 17% | N/A |